Delivery Order SPE2DB22D1041-SPE2DB25FUBU9
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency for the supply of Menquadfi vial 0.5ML pharmaceutical product. This competitively awarded, non-set-aside contract has a ceiling value of $2,905.80 with firm fixed pricing and an ultimate completion date of August 12, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menquadfi vial 0.5ml pharmaceutical products. This firm fixed-price delivery order, valued at $5,085.08, is due for completion by September 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain for the supply of Menquadfi vials (0.5ML), with a ceiling value of $2,179.35. This firm fixed-price, non-competitive set-aside delivery order was awarded on October 29, 2025, with an ultimate completion date of October 30, 2025. The contractor's place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) with a ceiling value of $8,254.21 under a firm fixed-price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 29, 2025, for Menquadfi vials (0.5mL). This firm fixed price delivery order, valued at $1,509.92, represents a competitive award with no set-aside designation and an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, aligning with the contractor's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,990.84 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, designated as a firm fixed-price delivery order without set-aside, covers the supply of Menquadfi vials (0.5mL), a meningococcal vaccine product. This award is issued as a child contract under...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 27, 2025, for MENQUADFI vials (0.5mL), with a contract value of $1,882.59 and an ultimate completion date of August 28, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for pharmaceutical supplies, specifically MENQUADFI vial 0.5ML, with a ceiling value of $1,452.88. This delivery order utilizes a firm fixed price contract type and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,233.00 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on July 1, 2025, with an ultimate completion date of July 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no...